Andrew Atz to Hypertension, Pulmonary
This is a "connection" page, showing publications Andrew Atz has written about Hypertension, Pulmonary.
Connection Strength
1.228
-
Simplified pulmonary vasodilatory testing in the cardiac catheterization laboratory with nasal cannula nitric oxide. Pediatr Cardiol. 2006 Jan-Feb; 27(1):84-86.
Score: 0.207
-
Vasopressin to attenuate pulmonary hypertension and improve systemic blood pressure after correction of obstructed total anomalous pulmonary venous return. J Thorac Cardiovasc Surg. 2005 Feb; 129(2):464-6.
Score: 0.194
-
Inhaled nitric oxide for pulmonary hypertension in patients with and without congenital heart disease: just say no! J S C Med Assoc. 1999 Sep; 95(9):349-51.
Score: 0.134
-
Preoperative management of pulmonary venous hypertension in hypoplastic left heart syndrome with restrictive atrial septal defect. Am J Cardiol. 1999 Apr 15; 83(8):1224-8.
Score: 0.130
-
Combined effects of nitric oxide and oxygen during acute pulmonary vasodilator testing. J Am Coll Cardiol. 1999 Mar; 33(3):813-9.
Score: 0.129
-
Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension. Lancet. 1998 Jun 06; 351(9117):1701.
Score: 0.123
-
Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg. 1996 Dec; 62(6):1759-64.
Score: 0.110
-
Inhaled nitric oxide in children with pulmonary hypertension and congenital mitral stenosis. Am J Cardiol. 1996 Feb 01; 77(4):316-9.
Score: 0.104
-
Population pharmacokinetics of sildenafil in extremely premature infants. Br J Clin Pharmacol. 2019 12; 85(12):2824-2837.
Score: 0.034
-
Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology. 1999 Jul; 91(1):307-10.
Score: 0.033
-
Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol. 1997 Oct; 21(5):441-55.
Score: 0.029